project id: TCGA-HNSC; case submitter id: TCGA-P3-A5QE; source center: 23; state: released; a260 a280 ratio: 1.92; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 9.1; age at index: 49; days to birth: -18002; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 18002; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage III; ajcc clinical t: T1; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1559.0; icd 10 code: C01; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Base of tongue, NOS; synchronous malignancy: No; tissue or organ of origin: Base of tongue, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Yes; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1217; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-P3-A5QE-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 75.0;